Karuna Therapeutics, Inc.

NASDAQ:KRTX

329.83 (USD) • At close March 15, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -433.68-276.336-143.805-68.554-43.957-17.512-6.032
Depreciation & Amortization 1.7011.1120.5060.1450.0580.0060.001
Deferred Income Tax 00000.1350.4440.055
Stock Based Compensation 74.59947.45129.81113.47112.5680.9580.215
Change In Working Capital 9.5274.77410.845-15.580.599-1.8560.563
Accounts Receivables 0.0571.693-1.750000
Inventory 0000000
Accounts Payables 4.3470.2431.0710.3180.278-0.5290.537
Other Working Capital 5.1232.83811.524-15.8980.321-1.3270.026
Other Non Cash Items -37.966-5.0071.7650.662-0.3262.5831.171
Operating Cash Flow -385.819-228.006-100.878-69.856-30.923-15.377-4.027
Investing Activities:
Investments In Property Plant And Equipment -2.917-0.915-3.072-0.419-0.115-0.132-0.013
Acquisitions Net 3.9241.2213.1490.4190.11500
Purchases Of Investments -1,520.528-930.28-400.829-344.213-231.718-4.9830
Sales Maturities Of Investments 1,363.124344.8381.213254.98257.49800
Other Investing Activites -3.924-1.221-3.149-0.419-0.11500
Investing Cash Flow -160.321-586.395-22.688-89.65-174.335-5.115-0.013
Financing Activities:
Debt Repayment 0000-3.12800
Common Stock Issued 487.897003.659330.07700
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -4.524855.777277.575-0.43978.33427.5774.25
Financing Cash Flow 483.373855.777277.5753.659405.28327.5774.25
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -62.76741.376154.009-155.847200.0257.0850.21
Cash At End Of Period 185.823248.59207.21453.205209.0529.0271.942